Cart
sales@molnova.com
Home - Products - Metabolic Enzyme/Protease - DPP - Retagliptin Phosphate

Retagliptin Phosphate

CAS No. 1256756-88-3

Retagliptin Phosphate( SP 2086 )

Catalog No. M23428 CAS No. 1256756-88-3

Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 In Stock
5MG 110 In Stock
10MG 177 In Stock
25MG 332 In Stock
50MG 502 In Stock
100MG 709 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Retagliptin Phosphate
  • Note
    Research use only, not for human use.
  • Brief Description
    Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
  • Description
    Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.
  • In Vitro
    Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect.
  • In Vivo
    ——
  • Synonyms
    SP 2086
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    DPP
  • Recptor
    DPP-4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1256756-88-3
  • Formula Weight
    562.36
  • Molecular Formula
    C19H21F6N4O7P
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 150 mg/mL (266.73 mM)
  • SMILES
    COC(C1=NC([N]2=C1CN(C(C[C@@H](CC3=C(F)C=C(F)C(F)=C3)N)=O)CC2)C(F)(F)F)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hu C, et al. Pharmacokinetics of Phosphate Retagliptin Tabletin in Patients with Renal Dysfunction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):74-80.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Cofrogliptin

    Cofrogliptin (HSK7653) is an orally available dipeptidyl peptidase-4 (DPP-4) inhibitor with hypoglycemic effects, which can be used to study type 2 diabetes (T2D).

  • P32/98 hemifumarate

    P32/98 hemifumarate is a dipeptidyl peptidase IV (DPP4) inhibitor with hypoglycemic properties that improves insulin sensitivity and β-cell responsiveness in the Zucker diabetic rat model, and may be useful in studies of type 2 diabetes and colitis.

  • Denagliptin

    Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine ü metabolic diseases and can be used in the study of type 2 diabetes.

Sign In Join Free